Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-07 06:37:30 - browse：298

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Study finds gene variants tied to breast cancer risk in Black women

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Biden targets hefty hospital 'facility fees' that often surprise patients

Pandemic and All Hazards Preparedness Act needs lean update

Listen: A conversation with researcher Kevin Esvelt on biosecurity

H5N1 virus can be tracked in retail milk, scientists say

Home health providers sue Medicare over payment cuts

hotspot

Wikipedia

entertainment

How to save PrEP access — and even expand it

Create a giant ice tray with this foil pan hack to keep food cold this summer

BioMarin wins approval for gene therapy to treat hemophilia A

Biden’s NIH nominee is languishing in Congress

Hollywood unions extend contract negotiations for actors

ACA's risk program benefits Blue Cross Blue Shield insurers

New air purifier tech could be key to improving indoor air quality

H5N1 virus can be tracked in retail milk, scientists say

Duchenne breakthrough therapy leaves behind pioneering families

Biogen joins immunology wave with $1.15 billion acquisition of HI

knowledge

Investigation reveals sickle cell patients pressured into sterilizations

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Swim instructor mom warns parents not to buy blue swimsuits for kids

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Pandemic and All Hazards Preparedness Act needs lean update

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

focus

hotspot

leisure time

knowledge